GlaxoSmithKline to ‘drop patents in poor countries for better drug access’
The British company said it would not file patents in these countries. Chief executive Sir Andrew Witty said he wanted to take a “graduated” approach to the company’s “intellectual property” based on the wealth of nations around the globe. Experts have described the plans as “brave and positive”. GSK hopes ... Read More »
